{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:21:09Z","timestamp":1756902069475,"version":"3.44.0"},"reference-count":21,"publisher":"The Pediatric Pharmacy Association","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"abstract":"<jats:p>Clinical manifestations of valproic acid (VPA) toxicity can range from just mild confusion and drowsiness to serious encephalopathy, leading to depressed sensorium and even coma and death. The exact cause(s) of how VPA influences the integrity of brain function remains unknown. Nevertheless, several mechanisms have been postulated including a surge in the blood ammonia concentration. Valproic acid\u2013induced hyperammonemic encephalopathy is a rare yet serious sequalae and that can lead to grave outcomes. We report a case of hyperammonemic encephalopathy with preserved liver function following a moderate VPA intoxication in a toddler, who was successfully managed conservatively. Additionally, we briefly discuss mechanistic basis of VPA toxicity and highlight some of the available potential therapies.<\/jats:p>","DOI":"10.5863\/1551-6776-26.2.210","type":"journal-article","created":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T23:05:45Z","timestamp":1613516745000},"page":"210-212","source":"Crossref","is-referenced-by-count":1,"title":["Valproate-Induced Hyperammonemic Encephalopathy Following Accidental Ingestion in a Toddler"],"prefix":"10.5863","volume":"26","author":[{"given":"Moftah","family":"Alhagamhmad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisha","family":"Elarwah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alia","family":"Alhassony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirin","family":"Alougly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamza","family":"Milad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aziza","family":"Dehoam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suliman","family":"Elbrgathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuri","family":"Shembesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emhemed","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulhamid","family":"ElShiky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","reference":[{"issue":"7","key":"i1551-6776-26-2-210-b1","series-title":"T J Res Med Sci","first-page":"3058","article-title":"Sodium valproate induced Stevens Johnson syndrome and hepatitis in a pediatric patient: a case report","volume":"4","year":"2016","unstructured":"Mugada\n              V,\n            \n            \n              Kakarparthy\n              R,\n            \n            \n              Ayinampudi\n              BK,\n            \n          \n          .\n\t\t\t\t\tSodium valproate induced Stevens Johnson syndrome and hepatitis in a pediatric patient: a case report.\n\t\t\t\t\tT J Res Med Sci.\n\t\t\t\t\t2016;\n\t\t\t\t\t4(\n\t\t\t\t\t7):\n\t\t\t\t\t3058\u2013\n\t\t\t\t\t3060."},{"issue":"suppl 2","key":"i1551-6776-26-2-210-b2","series-title":"Psychopharmacol Bull","first-page":"5","article-title":"The history of valproate in clinical neuroscience","volume":"37","year":"2003","unstructured":"Henry\n              TR.\n            \n          \n          The history of valproate in clinical neuroscience.\n\t\t\t\t\tPsychopharmacol Bull.\n\t\t\t\t\t2003;\n\t\t\t\t\t37(\n\t\t\t\t\tsuppl 2):\n\t\t\t\t\t5\u2013\n\t\t\t\t\t16."},{"issue":"4","key":"i1551-6776-26-2-210-b3","series-title":"Psych Clin Psychopharmacol","first-page":"448","article-title":"Hyperammonemic encephalopathy without hepatic dysfunction due to treatment with valproate: four cases and a mini review","volume":"28","year":"2018","unstructured":"Din\u00e7er\n              M,\n            \n            \n              Akg\u00fcn\n              A,\n            \n            \n              Bodur\n              \u015e,\n            \n          \n          .\n\t\t\t\t\tHyperammonemic encephalopathy without hepatic dysfunction due to treatment with valproate: four cases and a mini review.\n\t\t\t\t\tPsych Clin Psychopharmacol.\n\t\t\t\t\t2018;\n\t\t\t\t\t28(\n\t\t\t\t\t4):\n\t\t\t\t\t448\u2013\n\t\t\t\t\t460."},{"issue":"6","key":"i1551-6776-26-2-210-b4","series-title":"J Pharmac Sci Res","first-page":"818","article-title":"Sodium valproate induced hyperammonemia with normal liver function: a case report","volume":"9","year":"2017","unstructured":"Abraham\n              TC,\n            \n            \n              James\n              G,\n            \n            \n              Thomas\n              A,\n            \n          \n          .\n\t\t\t\t\tSodium valproate induced hyperammonemia with normal liver function: a case report.\n\t\t\t\t\tJ Pharmac Sci Res.\n\t\t\t\t\t2017;\n\t\t\t\t\t9(\n\t\t\t\t\t6):\n\t\t\t\t\t818\u2013\n\t\t\t\t\t823."},{"issue":"6","key":"i1551-6776-26-2-210-b5","series-title":"Seizure","first-page":"443","article-title":"Valproic acid induced encephalopathy\u201319 new cases in Germany from 1994 to 2003\u2013a side effect associated to VPA-therapy not only in young children","volume":"15","year":"2006","unstructured":"Gerstner\n              T,\n            \n            \n              Buesing\n              D,\n            \n            \n              Longin\n              E,\n            \n          \n          .\n\t\t\t\t\tValproic acid induced encephalopathy\u201319 new cases in Germany from 1994 to 2003\u2013a side effect associated to VPA-therapy not only in young children.\n\t\t\t\t\tSeizure.\n\t\t\t\t\t2006;\n\t\t\t\t\t15(\n\t\t\t\t\t6):\n\t\t\t\t\t443\u2013\n\t\t\t\t\t448."},{"issue":"2","key":"i1551-6776-26-2-210-b6","series-title":"Epilepsia","first-page":"154","article-title":"Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy","volume":"43","year":"2002","unstructured":"Vossler\n              DG,\n            \n            \n              Wilensky\n              AJ,\n            \n            \n              Cawthon\n              DF,\n            \n          \n          .\n\t\t\t\t\tSerum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy.\n\t\t\t\t\tEpilepsia.\n\t\t\t\t\t2002;\n\t\t\t\t\t43(\n\t\t\t\t\t2):\n\t\t\t\t\t154\u2013\n\t\t\t\t\t159."},{"key":"i1551-6776-26-2-210-b7","series-title":"Gen Hosp Psychiatry","first-page":"67","article-title":"Risk factors for valproic acid induced hyperammonemia and its association with cognitive functions","volume":"59","year":"2019","unstructured":"Duman\n              B,\n            \n            \n              Can\n              KC,\n            \n            \n              A\u011fta\u015f-Ertan\n              E,\n            \n          \n          .\n\t\t\t\t\tRisk factors for valproic acid induced hyperammonemia and its association with cognitive functions.\n\t\t\t\t\tGen Hosp Psychiatry.\n\t\t\t\t\t2019;\n\t\t\t\t\t59:\n\t\t\t\t\t67\u2013\n\t\t\t\t\t72."},{"issue":"6","key":"i1551-6776-26-2-210-b8","series-title":"Vet Human Toxicol","first-page":"438","article-title":"Hemodialysis and hemoperfusion for treatment of valproic acid and gabapentin poisoning","volume":"38","year":"1996","unstructured":"Fernandez\n              C,\n            \n            \n              Frank\n              GW,\n            \n            \n              James\n              CK,\n            \n          \n          .\n\t\t\t\t\tHemodialysis and hemoperfusion for treatment of valproic acid and gabapentin poisoning.\n\t\t\t\t\tVet Human Toxicol.\n\t\t\t\t\t1996;\n\t\t\t\t\t38(\n\t\t\t\t\t6):\n\t\t\t\t\t438\u2013\n\t\t\t\t\t443."},{"issue":"5","key":"i1551-6776-26-2-210-b9","series-title":"Crit Care","first-page":"431","article-title":"Science review: carnitine in the treatment of valproic acid-induced toxicity\u2013what is the evidence?","volume":"9","year":"2005","unstructured":"Lheureux\n              PER,\n            \n            \n              Penaloza\n              A,\n            \n            \n              Zahir\n              S,\n            \n          \n          .\n\t\t\t\t\tScience review: carnitine in the treatment of valproic acid-induced toxicity\u2013what is the evidence?Crit Care.\n\t\t\t\t\t2005;\n\t\t\t\t\t9(\n\t\t\t\t\t5):\n\t\t\t\t\t431\u2013\n\t\t\t\t\t430."},{"issue":"12","key":"i1551-6776-26-2-210-b10","series-title":"Ann Pharmacother","first-page":"2119","article-title":"Acute hyperammonemic coma with chronic valproic acid therapy","volume":"39","year":"2005","unstructured":"Cuturic\n              M,\n            \n            \n              Abramson\n              RK.\n            \n          \n          Acute hyperammonemic coma with chronic valproic acid therapy.\n\t\t\t\t\tAnn Pharmacother.\n\t\t\t\t\t2005;\n\t\t\t\t\t39(\n\t\t\t\t\t12):\n\t\t\t\t\t2119\u2013\n\t\t\t\t\t2123."},{"issue":"2","key":"i1551-6776-26-2-210-b11","series-title":"Neurol India","first-page":"226","article-title":"Valproate-induced hyperammonemic encephalopathy with normal liver function","volume":"53","year":"2005","unstructured":"Rath\n              A,\n            \n            \n              Naryanan\n              TJ,\n            \n            \n              Chowdhary\n              GVS,\n            \n          \n          .\n\t\t\t\t\tValproate-induced hyperammonemic encephalopathy with normal liver function.\n\t\t\t\t\tNeurol India.\n\t\t\t\t\t2005;\n\t\t\t\t\t53(\n\t\t\t\t\t2):\n\t\t\t\t\t226\u2013\n\t\t\t\t\t228."},{"issue":"7","key":"i1551-6776-26-2-210-b12","series-title":"Clin Toxicol","first-page":"661","article-title":"Valproic acid poisoning: an evidence-based consensus guideline for out-of-hospital management","volume":"46","year":"2008","unstructured":"Manoguerra\n              AS,\n            \n            \n              Erdman\n              AR,\n            \n            \n              Woolf\n              AD,\n            \n          \n          .\n\t\t\t\t\tValproic acid poisoning: an evidence-based consensus guideline for out-of-hospital management.\n\t\t\t\t\tClin Toxicol.\n\t\t\t\t\t2008;\n\t\t\t\t\t46(\n\t\t\t\t\t7):\n\t\t\t\t\t661\u2013\n\t\t\t\t\t676."},{"issue":"5","key":"i1551-6776-26-2-210-b13","series-title":"Hum Exp Toxicol","first-page":"453","article-title":"Fatal valproate overdose in a newborn baby","volume":"26","year":"2007","unstructured":"Unal\n              E,\n            \n            \n              Kaya\n              U,\n            \n            \n              Aydin\n              K.\n            \n          \n          Fatal valproate overdose in a newborn baby.\n\t\t\t\t\tHum Exp Toxicol.\n\t\t\t\t\t2007;\n\t\t\t\t\t26(\n\t\t\t\t\t5):\n\t\t\t\t\t453\u2013\n\t\t\t\t\t456."},{"issue":"9","key":"i1551-6776-26-2-210-b14","series-title":"Clin Chem","first-page":"1233","article-title":"The consequences of valproate overdose","volume":"57","year":"2011","unstructured":"Davison\n              AS,\n            \n            \n              Milan\n              AM,\n            \n            \n              Roberts\n              NB.\n            \n          \n          The consequences of valproate overdose.\n\t\t\t\t\tClin Chem.\n\t\t\t\t\t2011;\n\t\t\t\t\t57(\n\t\t\t\t\t9):\n\t\t\t\t\t1233\u2013\n\t\t\t\t\t1237."},{"issue":"1","key":"i1551-6776-26-2-210-b15","series-title":"Drug Saf","first-page":"65","article-title":"Acute valproic acid overdose","volume":"5","year":"1990","unstructured":"Dupuis\n              RE,\n            \n            \n              Lichtman\n              SN,\n            \n            \n              Pollack\n              GM.\n            \n          \n          Acute valproic acid overdose.\n\t\t\t\t\tDrug Saf.\n\t\t\t\t\t1990;\n\t\t\t\t\t5(\n\t\t\t\t\t1):\n\t\t\t\t\t65\u2013\n\t\t\t\t\t71."},{"key":"i1551-6776-26-2-210-b16","series-title":"Nouv Presse Med","first-page":"678","article-title":"Intoxication associated with sodium valproate","volume":"11","year":"1982","unstructured":"Garnier\n              R,\n            \n            \n              Fournier\n              E.\n            \n          \n          Intoxication associated with sodium valproate.\n\t\t\t\t\tNouv Presse Med.\n\t\t\t\t\t1982;\n\t\t\t\t\t11:\n\t\t\t\t\t678."},{"issue":"6","key":"i1551-6776-26-2-210-b17","series-title":"Curr Med Res Opin","first-page":"1039","article-title":"Valproate-induced hyperammonemic encephalopathy: a brief review","volume":"28","year":"2012","unstructured":"Lewis\n              C,\n            \n            \n              Deshpande\n              A,\n            \n            \n              Tesar\n              GE,\n            \n          \n          .\n\t\t\t\t\tValproate-induced hyperammonemic encephalopathy: a brief review.\n\t\t\t\t\tCurr Med Res Opin.\n\t\t\t\t\t2012;\n\t\t\t\t\t28(\n\t\t\t\t\t6):\n\t\t\t\t\t1039\u2013\n\t\t\t\t\t1042."},{"issue":"3","key":"i1551-6776-26-2-210-b18","series-title":"Hemodial Int","first-page":"256","article-title":"Acute hemolysis with acute renal failure in a patient with valproic acid poisoning treated with charcoal hemoperfusion","volume":"10","year":"2006","unstructured":"Rahman\n              MH,\n            \n            \n              Haqqie\n              SS,\n            \n            \n              McGoldrick\n              MD.\n            \n          \n          Acute hemolysis with acute renal failure in a patient with valproic acid poisoning treated with charcoal hemoperfusion.\n\t\t\t\t\tHemodial Int.\n\t\t\t\t\t2006;\n\t\t\t\t\t10(\n\t\t\t\t\t3):\n\t\t\t\t\t256\u2013\n\t\t\t\t\t259."},{"issue":"4","key":"i1551-6776-26-2-210-b19","series-title":"J Clin Neurosci","first-page":"690","article-title":"Valproate induced hyperammonemic encephalopathy successfully treated with levocarnitine","volume":"21","year":"2014","unstructured":"Rigamonti\n              A,\n            \n            \n              Giuseppe\n              L,\n            \n            \n              Gianluca\n              G,\n            \n          \n          .\n\t\t\t\t\tValproate induced hyperammonemic encephalopathy successfully treated with levocarnitine.\n\t\t\t\t\tJ Clin Neurosci.\n\t\t\t\t\t2014;\n\t\t\t\t\t21(\n\t\t\t\t\t4):\n\t\t\t\t\t690\u2013\n\t\t\t\t\t691."},{"issue":"3","key":"i1551-6776-26-2-210-b20","series-title":"Am J Therap","first-page":"344","article-title":"Levocarnitine for the treatment of valproic acid\u2013induced hyperammonemic encephalopathy in children: the experience of a large, tertiary care pediatric hospital and a poison center","volume":"26","year":"2019","unstructured":"Glatstein\n              M,\n            \n            \n              Bonifacio Rino\n              P,\n            \n            \n              de Pinho\n              S,\n            \n          \n          .\n\t\t\t\t\tLevocarnitine for the treatment of valproic acid\u2013induced hyperammonemic encephalopathy in children: the experience of a large, tertiary care pediatric hospital and a poison center.\n\t\t\t\t\tAm J Therap.\n\t\t\t\t\t2019;\n\t\t\t\t\t26(\n\t\t\t\t\t3):\n\t\t\t\t\t344\u2013\n\t\t\t\t\t349."},{"issue":"5","key":"i1551-6776-26-2-210-b21","series-title":"Clin Toxicol","first-page":"454","article-title":"Extracorporeal treatment for valproic acid poisoning: systematic review and recommendations from the EXTRIP workgroup","volume":"53","year":"2015","unstructured":"Ghannoum\n              M,\n            \n            \n              Lalibert\u00e9\n              M,\n            \n            \n              Nolin\n              TD,\n            \n          \n          .\n\t\t\t\t\tExtracorporeal treatment for valproic acid poisoning: systematic review and recommendations from the EXTRIP workgroup.\n\t\t\t\t\tClin Toxicol.\n\t\t\t\t\t2015;\n\t\t\t\t\t53(\n\t\t\t\t\t5):\n\t\t\t\t\t454\u2013\n\t\t\t\t\t465."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/26\/2\/article-p210.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/jppt\/article-pdf\/26\/2\/210\/2773567\/i1551-6776-26-2-210.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/26\/2\/article-p210.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/26\/2\/article-p210.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:44:44Z","timestamp":1747356284000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/26\/2\/article-p210.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":21,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-26.2.210","relation":{},"ISSN":["1551-6776"],"issn-type":[{"type":"print","value":"1551-6776"}],"subject":[],"published":{"date-parts":[[2021]]}}}